41 results about "Copd patients" patented technology

Handheld medical diagnostic instrument that provides high time-resolution pulse waveforms associated with multiple parameters including blood pressure measurements, blood oxygen saturation levels, electrocardiograph (ECG) measurements, and temperature measurements. The device stores and analyzes the pulse waveforms simultaneously obtained from all tests, and thereby allows an unusually detailed view into the functioning of the user's cardiovascular heart-lung system. The device is designed for use by unskilled or semi-skilled users, thus enabling sophisticated cardiovascular measurements to be obtained in a home environment. Data from the device can be analyzed onboard, with local computerized devices, and with remote server based systems. The remote server may be configured to analyze this data according to various algorithms chosen by the physician to be most appropriate to that patient's particular medical condition (e.g. COPD patient algorithms). The server may be further configured to automatically provide alerts and drug recommendations.

The invention discloses apparatus, systems and methods for detecting a severity change in respiratory insufficiency or chronic obstructive pulmonary disease. The supplied pressure may optionally be determined during pressure treatment that satisfies a target ventilation. The supplied pressure or representative data may be compared to one or more thresholds that are selected to represent a change in the condition of the RI or COPD patient such as an exacerbation of a prior condition. Results of the comparisons may trigger one or more warnings or messages to notify a patient or physician of a pending change to the patient's RI or COPD condition so that the patient may more immediately seek medical attention to treat the condition.

The invention provides a method for estimating if a patient suffering from Chronic Obstructive Pulmonary Disease (COPD) is approaching an exacerbation. Data with connected data indicative of levels of blood oxygen saturation obtained from the patient and their respective time of measurements are received, and a processor executes an algorithm involving: 1) calculating a statistical measure, e.g. a regression, of the level of blood oxygen saturation data taking into account available data within a time window with a limited length back in time, e.g. 30 days back in time, and 2) estimating if the patient is approaching an exacerbation by comparing a value obtained from said statistical measure to a reference value. Finally, an output indicative of a result of said estimation is generated. The method can ensure that COPD patients, e.g. in tele homecare, are properly treated before suffering from a severe exacerbation that could necessitate hospitalization. The COPD patient can easily measure blood oxygen saturation with an oxygen meter, and the algorithm can be executed on a mobile phone, a PC, on a server in contact with the patient via the interne, or on a dedicated oxygen meter device.

Handheld medical diagnostic instrument that provides high time-resolution pulse waveforms associated with multiple parameters including blood pressure measurements, blood oxygen saturation levels, electrocardiograph (ECG) measurements, and temperature measurements. The device stores and analyzes the pulse waveforms simultaneously obtained from all tests, and thereby allows an unusually detailed view into the functioning of the user's cardiovascular heart-lung system. The device is designed for use by unskilled or semi-skilled users, thus enabling sophisticated cardiovascular measurements to be obtained in a home environment. Data from the device can be analyzed onboard, with local computerized devices, and/or with remote server based systems. The device or remote server may be configured to analyze this data according to various algorithms chosen by the physician to be most appropriate to that patient's particular medical condition (e.g. COPD patient algorithms). The device or remote server may be further configured to automatically provide alerts and drug recommendations.

The invention provides traditional Chinese medicine composition for treating the stationary-phase COPD (chronic obstructive pulmonary disease). The composition comprises raw materials in parts by weight as follows: 47 parts of codonopsis radix, 59 parts of light wheat, 35 parts of fried largehead atractylodes rhizome, 23 parts of prepared pinellia tuber, 47 parts of dried tangerine peel, 35 parts of perilla fruit, 35 parts of divaricate saposhnikovia root, 35 parts of poria cocos, 59 parts of raw coix seed, 35 parts of honey-fried common coltsfoot flower, 35 parts of baical skullcap root, 35 parts of bulbus fritillariae pallidiflorae and 35 parts of honey-fried loquat leaf. The traditional Chinese medicine composition can prolong the second-time acute exacerbation time interval of a COPD patient by 77.68 days, decrease acute exacerbation times by 1.46 times per half a year, shorten the acute exacerbation duration by 2.93 days, decrease mMRC and CAT scores, improve clinical symptoms such as coughing, expectoration, shortness of breath, spontaneous perspiration, lacking in strength and the like, and enhance the exercise tolerance (that is, the 6MWD is increased). The composition has no side effect in a taking process of the clinical patient, so that the composition is a safe and effective prescription for treating the stationary-phase COPD.

The invention discloses an ICF evaluation system for chronic obstructive pulmonary respiratory rehabilitation, based on Internet of Things. The ICF evaluation system includes a data collection terminal, a digitizer, a cloud processor, an ICF evaluation terminal, and a clinical server, wherein the digitizer collects data related to a COPD patient; the data collection terminal communicates with thecloud processor, and the cloud processor analyzes the obtained data to generate preliminary ICF evaluation and recommended rehabilitation opinions and transmit the preliminary ICF evaluation and recommended rehabilitation opinions to the ICF evaluation terminal; and the ICF evaluation terminal generates ICF evaluation results and rehabilitation guidance opinions, and the ICF evaluation results andthe rehabilitation guidance opinions are transmitted to the clinical server through the cloud processor. The ICF evaluation system for chronic obstructive pulmonary respiratory rehabilitation, basedon Internet of Things is able to complete ICF multi-dimensional evaluation according to the COPD patient-related scale data and provide rehabilitation treatment schemes for patients.

Systems and methods for monitoring subjects after discharge from a hospital use a dynamic baseline to determine whether a caregiver needs to be notified regarding exacerbation of a medical state of a subject. The subjects are chronic obstructive pulmonary disease (COPD) patients. The dynamic baseline is determined by aggregating (for example averaging) multiple values of a sequence of values for a metric that quantifies one or both of a patient symptom (e.g. the number of overnight apnea occurrences) and/or lung function of a subject (e.g. forced expiratory volume in 1 second). Multiple metrics may be combined to generate the value that is monitored for a subject.

The present invention relates to pharmaceutical products comprising fluticasone furoate for use in the treatment of COPD patients, particularly a subgroup of COPD patients that through analysis have been identified as possessing an eosinophil blood count of≧150 cells/W. The present invention is further directed to methods for treating a patient with COPD which methods include identifying a patient that will respond to treatment and administering a pharmaceutical product of the present invention comprising fluticasone furoate to said patient.

The invention relates to a medical management system for a Chronic Obstructive Pulmonary Disease (COPD). The medical management system includes a COPD management platform provided with a first buttingport used for registering COPD patient data at a medical diagnosis and treatment mechanism, a second butting port used when medical care personnel regularly make a visit to COPD patients and an information communication platform used for doctor-patient communication and medical care personnel communication; and a COPD service platform used for analyzing disease information of the COPD patients collected by the first butting port and second butting port to generate a treatment and diagnosis scheme which includes one or more of medical care resource allocation, a drug diagnosis prescription anda life exercise prescription. The medical management system can provide proactive, standard, long-lasting and homogeneous management of the COPD patients, thereby improving the overall capability andlevel of medical services of the COPD.

The invention provides a COPD disease auxiliary diagnosis monitoring system based on big data, and the system comprises an acquisition module, a subset generation module, a calculation module and a monitoring device. The acquisition module is used for acquiring COPD disease data in a database, and the COPD disease data comprises COPD patient information and COPD patient clinical information; the subset generation module is used for obtaining a first number of disease features in the COPD disease data and obtaining a feature subset through an MDF algorithm; the calculation module is used for classifying the feature subsets based on a first algorithm and outputting a judgment result; the monitoring device is used for monitoring the physical signs of the patient in real time and comprises a lung monitoring unit and a nail monitoring unit. According to the invention, multi-dimensional data features can be mined; a COPD disease analysis algorithm is designed for deep learning, a COPD diagnosis model is optimized, and the system is applied to clinical auxiliary diagnosis, is an approach for applying medical big data to COPD clinical auxiliary diagnosis, and has great significance in perfection, development and practicability of an information system data model in the medical field.

The invention provides an intelligent dynamic blood oxygen monitoring method. The method comprises the steps of arranging a blood oxygen finger sleeve, placing a finger of a human body between an infrared transmitting tube and an infrared receiving tube, and collecting the blood oxygen information of the human body through the combination of the infrared transmitting tube and the infrared receiving tube; setting a monitoring body, transmitting the blood oxygen information of the human body collected by the blood oxygen finger sleeve to the monitoring body for processing via a transmission cable and displaying the information via a display panel; setting a remote control terminal, and controlling a detection body to operate or receiving display signals sent by the detection body for processing to form diagnosis evaluation. The method can preliminarily screen patients with sleep apnea, can compare pre-treatment and post-treatment blood oxygen effects of patients and perform reexamination, can perform continuous evaluation and detection on treatment effects before using a breathing machine and after using a breathing machine of COPD patients and can guarantee long-time effective treatment of patients with sleep disordered breathing and the COPD patients; on the condition that some places are inconvenient, the remote control terminal can be utilized to perform processing and analysis conveniently according to data, so that the operation is more flexible.

A system, a method, and a computer program for providing COPD and similar management service are disclosed. The system may include three main branches: patients, users and a service provider. The service provider provides management services of the COPD patients to the users.

The invention relates to the technical field of preparation of Uygur medicinal material compositions, in particular to a Uygur medicinal material composition and a preparation method and application thereof. The raw materials of the Uygur medicinal material composition include, in parts by weight, nepeta bracteata and Iris halophila Pall. roots. The preparation method of the composition comprisesthe following steps: step 1, adding water to nepeta bracteata and Iris halophila Pall. roots of the required amount, performing reflux extraction so as to obtain a distillate and an extract, and thenfiltering the extract; step 2, adding water to the medicine dregs obtained after filtration in the previous step, performing reflux extraction continuously, filtering the extract, merging the two filtrates, and performing concentration so as to obtain a concentrated solution; and step 3, adding ethanol to the concentrated solution obtained in the previous step, performing still standing for 8-12 h, then removing the ethanol so as to obtain an alcoholized solution, adding the distillate obtained in the step 1 to the alcoholized solution, and performing mixing so as to prepare the Uygur medicinematerial composition. Through the Uygur medicine material composition, the lung function of COPD patients can be improved effectively, airway inflammatory factors can be reduced significantly, a significant curative effect is achieved during inflammation antagonism, and a new way is provided for treatment of COPD.

The invention provides a chronic obstructive pulmonary disease prediction method based on reconstructed airway tree images and relates to the medical image processing technology field. The method comprises steps that firstly, multi-layer CT image files of COPD patients and healthy people from the same hospital are collected, reconstructed airway tree images of the healthy people and the COPD patients are generated, different perspectives are changed to take a screenshot of the reconstructed airway tree images of the healthy person and COPD patients, the redundant background information of theairway tree images after screenshot taking is then removed, based on the convolutional neural network, training and classification are performed, and whether a test set has some COPD patients is predicted; and lastly, cross validation of an image set after reconstructed airway tree screenshot is performed, and accuracy of the prediction result is guaranteed. The method is advantaged in that the method is taken as a technical means to initially screen the disease, the method is accurate and efficient, misdiagnosis and missed diagnosis are effectively avoided, the complex process of lung function tests is further omitted, and the workload of the hospital is greatly reduced.

The present invention provides methods of treating a mammal having chronic obstructive pulmonary disease (COPD), independent of both smoking status and asthma status, with a therapeutically effective amount of an anti-IgE moiety. In accordance with the invention, COPD patients with an elevated serum IgE level may benefit from the treatment methods disclosed. In certain instances, the methods of the disclosure have been found to be useful for the treatment of COPD patients regardless of their skin test results and/or in vitro reactivity to a perennial aeroallergen. Anti-IgE moieties, in accordance with the invention, include but are not limited to any IgG antibody that selectively binds to a given mammal immunoglobulin E (e.g., human immunoglobulin E) such as humanized anti-IgE, humanized murine monoclonal antibody, and/or Omalizumab.

The invention provides an application of specific lectin combination in construction of a test tool for identifying adenocarcinoma (ADC) in lung cancer based on saliva glycoprotein carbohydrate chains, wherein the specific lectin combination is selected from four kinds of lectin of PHA-E+L, STL, WFA and Jacalin. Compared with lung squamous cell carcinoma (SCC) and small cell lung cancer (SCLC) samples, an adenocarcinoma (ADC) sample shows significantly different expression of the specific lectin combination. Moreover, a model is also established and shown in the specification; if the detectionvalue is greater than or equal to 0.697, it is indicated that the subject to which a saliva sample belongs to is an ADC patient, or otherwise, the subject to which the saliva sample belongs is otherlung disease patients (SCC, SCLC or COPD patients).

The invention relates to an application of CCR1 as a COPD diagnostic marker. A method comprises the following steps: detecting the peripheral blood and sputum (except the healthy control group) neutrophil oxidative phagocytic function and the expression level of related receptors of 30 healthy control groups, 30 pneumonia patients and 30 COPD patients by using FCM, and analyzing the inter-group difference. The result is as follows: compared with a healthy control group, the oxidative phagocytic function of neutrophils in peripheral blood and sputum of a COPD patient group and the expression ofa surface CCR1 receptor are obviously reduced (P is less than 0.05); compared with the pneumonia control group, the difference of oxidative phagocytic functions of neutrophils in peripheral blood hasno statistical significance, but in sputum, a COPD patient group is obviously lower than a pneumonia control group, the expression of neutrophil surface receptors CCR1 in the sputum of the COPD patient group is obviously higher than that of the pneumonia control group, and the difference has statistical significance (P is less than 0.05).

Said invention is an apparatus that sits on the ground and is close to the ground. Users sit on a Seat Pan and lean back on parallel Rails. Said apparatus has a Pivot Point which allows users to rock back and inhale and rock forward and exhale. These simple actions help everyone breathe better. These simple actions reverses belly breathing, reengages diaphragm breathing and builds the core muscles necessary to support diaphragm breathing. Belly breathing is when the belly extends with a deep inhale. Diaphragm breathing is when the chest expands with a deep inhale. Not all belly breathers have COPD, but all COPD patients are belly breathers. Reengaging diaphragm breathing increases airflow thereby reducing symptoms of early COPD. Belly breathers have difficulty exhaling CO₂. CO₂ builds up creating an acidic environment, which is associated with many diseases. The Breathing Rocker helps eliminate CO₂ buildup in the lungs.

A method of treating a human male patient is disclosed. Enterally administering bedoradrine or a pharmaceutically acceptable salt thereof to a human male patient who is suffering from a medical condition that is responsive to bedoradrine or a pharmaceutically acceptable salt thereof, is useful and benefits human males versus human females. A preferred mode of administration is oral administration.